These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8882375)

  • 21. Passive immunization against hepatitis A.
    Stapleton JT
    Vaccine; 1992; 10 Suppl 1():S45-7. PubMed ID: 1335658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity and safety of an inactivated hepatitis A vaccine when coadministered with Diphtheria-tetanus-acellular pertussis and haemophilus influenzae type B vaccines in children 15 months of age.
    Trofa AF; Klein NP; Paul IM; Michaels MG; Goessler M; Chandrasekaran V; Blatter M
    Pediatr Infect Dis J; 2011 Sep; 30(9):e164-9. PubMed ID: 21494175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epaxal: a virosomal vaccine to prevent hepatitis A infection.
    Bovier PA
    Expert Rev Vaccines; 2008 Oct; 7(8):1141-50. PubMed ID: 18844588
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
    Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
    Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Guidelines for the control of hepatitis A virus infection.
    Crowcroft NS; Walsh B; Davison KL; Gungabissoon U;
    Commun Dis Public Health; 2001 Sep; 4(3):213-27. PubMed ID: 11732363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatitis A vaccine: ready for prime time.
    Duff B; Duff P
    Obstet Gynecol; 1998 Mar; 91(3):468-71. PubMed ID: 9491879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The epidemiology and control of hepatitis A.
    Maguire H; Heptonstall J; Begg NT
    Commun Dis Rep CDR Rev; 1992 Sep; 2(10):R114-7. PubMed ID: 1284926
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunopotentiating reconstituted influenza virus virosome vaccine delivery system for immunization against hepatitis A.
    Glück R; Mischler R; Brantschen S; Just M; Althaus B; Cryz SJ
    J Clin Invest; 1992 Dec; 90(6):2491-5. PubMed ID: 1334977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatitis A virus infection and hepatitis A vaccination in human immunodeficiency virus-positive patients: A review.
    Lin KY; Chen GJ; Lee YL; Huang YC; Cheng A; Sun HY; Chang SY; Liu CE; Hung CC
    World J Gastroenterol; 2017 May; 23(20):3589-3606. PubMed ID: 28611512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Prevention of hepatitis A and hepatitis B with vaccination].
    Buisson Y; Meyran M
    Bull Acad Natl Med; 1995 Feb; 179(2):367-74; discussion 373-5. PubMed ID: 7614064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
    Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
    Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost-effectiveness of hepatitis A vaccination in patients with chronic hepatitis C.
    Myers RP; Gregor JC; Marotta PJ
    Hepatology; 2000 Apr; 31(4):834-9. PubMed ID: 10733536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis A vaccines.
    Nothdurft HD
    Expert Rev Vaccines; 2008 Jul; 7(5):535-45. PubMed ID: 18564009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Safety observation of attenuated live hepatitis B vaccine (H2 strain) in humans].
    Zhang S
    Zhonghua Yi Xue Za Zhi; 1990 Dec; 70(12):682-4, 48. PubMed ID: 1963372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single-Dose Hepatitis A Immunization: 7.5-Year Observational Pilot Study in Nicaraguan Children to Assess Protective Effectiveness and Humoral Immune Memory Response.
    Mayorga O; Bühler S; Jaeger VK; Bally S; Hatz C; Frösner G; Protzer U; Van Damme P; Egger M; Herzog C
    J Infect Dis; 2016 Nov; 214(10):1498-1506. PubMed ID: 27601623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Past infection with hepatitis A virus among Vancouver street youth, injection drug users and men who have sex with men: implications for vaccination programs.
    Ochnio JJ; Patrick D; Ho M; Talling DN; Dobson SR
    CMAJ; 2001 Aug; 165(3):293-7. PubMed ID: 11517645
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus?
    Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM
    J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Considerations of HAV vaccine in India.
    Mathur P; Arora NK
    Indian J Pediatr; 1999; 66(1):111-20. PubMed ID: 10798043
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Screening policy for travellers from Rotterdam for hepatitis A antibodies prior to eventual immunization: favourable cost-benefit ratio].
    Reintjes R; Bosman A; de Zwart O
    Ned Tijdschr Geneeskd; 1999 Aug; 143(35):1777-80. PubMed ID: 10494329
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Supplementary statement on hepatitis A prevention.
    Can Commun Dis Rep; 1996 Jan; 22(1):1-3. PubMed ID: 8825660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.